Faculty profile

Elissavet Kardami

ResearcherHuman Anatomy & Cell ScienceUniversity of Manitoba

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Manitoba directory, so their courses and email address may be missing. Find their university profile.

Elissavet Kardami

Researcher

Human Anatomy & Cell Science

Health Sciences

University of Manitoba

Winnipeg, Manitoba, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
3 publications in the last five years, latest in 2024.
Principal investigator on 2 research grants (2 CIHR), most recently in 2015.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cardiac Hypertrophy Cardiac Remodeling Fibroblast Growth Factor 2 Isoforms Fibroblasts Neuropilin 1 Translational Application

Latest papers

Diastolic Dysfunction with Normal Ejection Fraction and Reduced Heart Rate in Mice Expressing Human Growth Hormone and Displaying Signs of Growth Hormone Insufficiency.
International journal of molecular sciences · 2024
Increased capacity to maintain glucose homeostasis in a transgenic mouse expressing human but not mouse growth hormone with developing high-fat diet-related insulin resistance, hepatic steatosis and adipose dysfunction.
Journal of molecular endocrinology · 2024
Effect of high fat diet on maternal behavior, brain-derived neurotrophic factor and neural stem cell proliferation in mice expressing human placental lactogen during pregnancy.
Journal of neuroendocrinology · 2024

All 40 publications

Latest funding

The role of FGF2 isoforms in cardiac remodeling
CIHR · 2015 · Nominated PI
$646,363
FGF2 Isoforms in Cardiac Hypertrophy
CIHR · 2009 · Nominated PI
$818,110
CIHR IMPACT Strategic Training Program
CIHR · 2008 · Co-investigator
$1,950,000

All 3 grants and awards

40 publications.

Diastolic Dysfunction with Normal Ejection Fraction and Reduced Heart Rate in Mice Expressing Human Growth Hormone and Displaying Signs of Growth Hormone Insufficiency.

Jin Y, Xiang B, Dolinsky VW, Kardami E, Cattini PA

International journal of molecular sciences2024

DOI: 10.3390/ijms26010269 PMID: 39796124

Increased capacity to maintain glucose homeostasis in a transgenic mouse expressing human but not mouse growth hormone with developing high-fat diet-related insulin resistance, hepatic steatosis and adipose dysfunction.

Jin Y, Jarmasz JS, Sultana S, Cordero-Monroy L, Taylor CG, Zahradka P, Kardami E, Cattini PA

Journal of molecular endocrinology2024

DOI: 10.1530/jme-24-0026 PMID: 38832641

Effect of high fat diet on maternal behavior, brain-derived neurotrophic factor and neural stem cell proliferation in mice expressing human placental lactogen during pregnancy.

Moazzam S, Noorjahan N, Jin Y, Nagy JI, Kardami E, Cattini PA

Journal of neuroendocrinology2024

DOI: 10.1111/jne.13258 PMID: 36989439

A Cardiac Mitochondrial FGFR1 Mediates the Antithetical Effects of FGF2 Isoforms on Permeability Transition.

Srisakuldee W, Nickel BE, Fandrich RR, Zhang F, Pasumarthi KBS, Kardami E

Cells2021Senior author

DOI: 10.3390/cells10102735 PMID: 34685716

Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression.

Koleini N, Nickel BE, Nagalingam RS, Landry NM, Fandrich RR, Cheung DYC, Dixon IM, Czubryt MP, Jassal DS, Cattini PA, Kardami E

Cell and tissue research2021Senior author

DOI: 10.1007/s00441-021-03465-0 PMID: 34057573

SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.

Landry NM, Rattan SG, Filomeno KL, Meier TW, Meier SC, Foran SJ, Meier CF, Koleini N, Fandrich RR, Kardami E, Duhamel TA, Dixon IMC

Basic research in cardiology2021

DOI: 10.1007/s00395-021-00865-9 PMID: 33847835

Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes.

Shojaei S, Koleini N, Samiei E, Aghaei M, Cole LK, Alizadeh J, Islam MI, Vosoughi AR, Albokashy M, Butterfield Y, Marzban H, Xu F, Thliveris J, Kardami E, Hatch GM, Eftekharpour E, Akbari M, Hombach-Klonisch S, Klonisch T, Ghavami S

The FEBS journal2020

DOI: 10.1111/febs.15069 PMID: 31545550

Low and High Molecular Weight FGF-2 Have Differential Effects on Astrocyte Proliferation, but Are Both Protective Against Aβ-Induced Cytotoxicity.

Chen X, Li Z, Cheng Y, Kardami E, Loh YP

Frontiers in molecular neuroscience2019

DOI: 10.3389/fnmol.2019.00328 PMID: 32038161

Oxidized phospholipids in Doxorubicin-induced cardiotoxicity.

Koleini N, Nickel BE, Edel AL, Fandrich RR, Ravandi A, Kardami E

Chemico-biological interactions2019Senior author

DOI: 10.1016/j.cbi.2019.01.032 PMID: 30707978

Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity.

Koleini N, Santiago JJ, Nickel BE, Sequiera GL, Wang J, Fandrich RR, Jassal DS, Dhingra S, Kirshenbaum LA, Cattini PA, Kardami E

American journal of physiology. Heart and circulatory physiology2019Senior author

DOI: 10.1152/ajpheart.00587.2018 PMID: 30412444

Something wrong or missing on this profile? Suggest a correction

Elissavet Kardami

Research

Latest papers

Latest funding

Diastolic Dysfunction with Normal Ejection Fraction and Reduced Heart Rate in Mice Expressing Human Growth Hormone and Displaying Signs of Growth Hormone Insufficiency.

Increased capacity to maintain glucose homeostasis in a transgenic mouse expressing human but not mouse growth hormone with developing high-fat diet-related insulin resistance, hepatic steatosis and adipose dysfunction.

Effect of high fat diet on maternal behavior, brain-derived neurotrophic factor and neural stem cell proliferation in mice expressing human placental lactogen during pregnancy.

A Cardiac Mitochondrial FGFR1 Mediates the Antithetical Effects of FGF2 Isoforms on Permeability Transition.

Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression.

SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.

Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes.

Low and High Molecular Weight FGF-2 Have Differential Effects on Astrocyte Proliferation, but Are Both Protective Against Aβ-Induced Cytotoxicity.

Oxidized phospholipids in Doxorubicin-induced cardiotoxicity.

Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity.

The role of FGF2 isoforms in cardiac remodeling

FGF2 Isoforms in Cardiac Hypertrophy

CIHR IMPACT Strategic Training Program

Frequent collaborators

Thomas Klonisch

Sabine Hombach-Klonisch

Sanjiv Dhingra

Mohsen Akbari

Samer Mansour

Carla Taylor

Ryan Zarychanski

Elissavet Kardami

Research

Latest papers

Latest funding

Diastolic Dysfunction with Normal Ejection Fraction and Reduced Heart Rate in Mice Expressing Human Growth Hormone and Displaying Signs of Growth Hormone Insufficiency.

Increased capacity to maintain glucose homeostasis in a transgenic mouse expressing human but not mouse growth hormone with developing high-fat diet-related insulin resistance, hepatic steatosis and adipose dysfunction.

Effect of high fat diet on maternal behavior, brain-derived neurotrophic factor and neural stem cell proliferation in mice expressing human placental lactogen during pregnancy.

A Cardiac Mitochondrial FGFR1 Mediates the Antithetical Effects of FGF2 Isoforms on Permeability Transition.

Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression.

SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.

Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes.

Low and High Molecular Weight FGF-2 Have Differential Effects on Astrocyte Proliferation, but Are Both Protective Against A&#x3b2;-Induced Cytotoxicity.

Oxidized phospholipids in Doxorubicin-induced cardiotoxicity.

Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity.

The role of FGF2 isoforms in cardiac remodeling

FGF2 Isoforms in Cardiac Hypertrophy

CIHR IMPACT Strategic Training Program

Frequent collaborators

Thomas Klonisch

Sabine Hombach-Klonisch

Sanjiv Dhingra

Mohsen Akbari

Samer Mansour

Carla Taylor

Ryan Zarychanski

Low and High Molecular Weight FGF-2 Have Differential Effects on Astrocyte Proliferation, but Are Both Protective Against Aβ-Induced Cytotoxicity.